largest
deadliest
outbreak
ebola
viru
diseas
began
decemb
year
old
child
develop
ill
character
fever
black
stool
vomit
town
call
meliand
guineaa
remot
spars
popul
villag
household
approxim
mile
border
liberia
sierra
leon
exact
sourc
infect
unclear
like
involv
contact
infect
anim
child
die
th
day
ill
next
three
week
child
year
old
sister
mother
grandmoth
also
die
two
women
nearbi
villag
attend
funer
child
grandmoth
die
three
week
later
midwif
child
villag
hospit
subsequ
die
two
healthcar
worker
work
hospit
midwif
admit
also
becam
ill
die
multipl
famili
member
attend
funer
healthcar
worker
also
becam
ill
die
ill
initi
thought
cholera
spread
sever
surround
district
well
capit
guinea
conkari
citi
million
peopl
march
case
identifi
neighbor
liberia
diseas
identifi
caus
ebola
viru
april
case
ebola
viru
diseas
evd
identifi
sierra
leon
guinea
liberia
sierra
leon
previous
never
experienc
outbreak
evd
previou
evd
outbreak
occur
mostli
rural
villag
central
african
nation
democrat
republ
congo
sudan
gabon
uganda
republ
congo
prior
largest
document
evd
outbreak
occur
gulu
district
uganda
result
case
death
decemb
west
africa
evd
outbreak
result
case
death
guinea
liberia
sierra
leonemor
previou
evd
outbreak
combin
outbreak
provid
opportun
learn
import
lesson
key
domain
critic
prepar
futur
outbreak
evd
seriou
communic
diseas
safe
effect
patient
care
role
experiment
therapeut
vaccin
infect
control
hospit
commun
prepared
specif
therapi
approv
us
food
drug
administr
treatment
evd
therefor
primari
treatment
evd
support
care
specif
fluid
replac
electrolyt
manag
prior
west
africa
outbreak
abil
health
care
worker
provid
aggress
support
care
often
hamper
resourc
limit
mani
central
african
ebola
treatment
center
oral
rehydr
though
readili
avail
even
resourcelimit
set
may
inadequ
given
sever
fluid
loss
liter
per
day
caus
evdassoci
gastroenter
intract
nausea
vomit
frequent
accompani
ill
similarli
abil
safe
provid
intraven
fluid
rehydr
correct
electrolyt
abnorm
often
limit
inadequ
staf
limit
suppli
intraven
fluid
inadequ
unavail
laboratori
test
laboratori
test
avail
outbreak
sudan
ebolaviru
uganda
demonstr
renal
failur
liver
failur
hypocalcemia
hypoalbuminemia
elev
ddimer
associ
increas
mortal
histor
size
west
africa
evd
outbreak
requir
intern
respons
result
construct
new
ebola
treatment
unit
guinea
liberia
sierra
leon
well
treatment
individu
western
europ
unit
state
result
abil
heath
care
worker
provid
aggress
support
care
enhanc
conakri
guinea
aggress
support
care
may
contribut
reduc
case
fatal
rate
compar
resourcelimit
area
countri
compar
histor
cohort
among
patient
evacu
western
europ
unit
state
major
patient
signific
electrolyt
abnorm
hyponatriemia
hypokalemia
hypocalcemia
hypomagnesemia
diagnos
laboratori
monitor
patient
receiv
multipl
differ
sometim
overlap
intervent
includ
support
care
casefat
proport
patient
treat
western
europ
unit
state
substanti
lower
mortal
seen
west
africa
etu
treatment
evd
patient
resourceenhanc
set
like
western
europ
unit
state
also
allow
patient
evdassoci
multiorgan
system
failur
receiv
first
time
advanc
critic
care
intervent
like
mechan
ventil
renal
replac
therapi
multiorgan
system
failur
evd
histor
west
africa
outbreak
associ
poor
outcom
howev
patient
treat
western
europ
unit
state
requir
advanc
critic
care
intervent
noninvas
mechan
ventil
mechan
ventil
vasopressor
inotrop
support
renal
replac
therapi
six
surviv
addit
experi
provid
critic
care
support
patient
evd
demonstr
invas
intervent
like
mechan
ventil
renal
replac
therapi
perform
safe
perform
train
health
care
worker
strictli
adher
infect
control
practic
clinic
care
patient
evd
end
resolut
viremia
evd
survivor
develop
divers
array
complic
convalesc
survivor
outbreak
bundibugyo
ebolaviru
uganda
develop
joint
pain
sleep
disturb
neurolog
abnorm
includ
hear
loss
memori
loss
confus
addit
ocular
complaint
includ
retroorbit
pain
blur
vision
common
ocular
complaint
includ
sightthreaten
uveiti
also
describ
survivor
outbreak
zair
ebolaviru
kikwit
democrat
republ
congo
small
survey
evd
survivor
west
africa
particip
report
eye
problem
current
outbreak
one
survivor
develop
sever
uveiti
convalesc
viabl
ebola
viru
isol
anterior
eye
chamber
week
clearanc
viremia
pathogenesi
complic
occur
evd
convalesc
unclear
may
multifactori
hypothes
complic
may
relat
postvir
autoimmun
diseas
also
postul
complic
may
persist
viral
replic
immuneprivileg
site
persist
viabl
ebola
viru
isol
semen
aqueou
humor
evd
survivor
addit
one
survivor
develop
meningoenceph
month
clear
viremia
ebola
viru
isol
cerebrospin
fluid
unclear
whether
ebola
viru
persist
bodili
fluid
tissu
thought
immuneprivileg
eg
synovi
fluid
prospect
cohort
studi
underway
west
africa
hope
elucid
caus
complic
occur
evd
survivor
convalesc
key
surviv
ebola
viru
diseas
aggress
support
care
possibl
discoveri
effect
therapeut
agent
may
improv
patient
outcom
unfortun
disproportion
media
attent
unproven
therapeut
recent
ebola
outbreak
led
unrealist
expect
almost
univers
compassion
use
experiment
therapeut
patient
repatri
resourcerich
center
patient
treat
resourcerich
center
receiv
least
two
investig
therapeut
despit
fact
none
human
efficaci
safeti
data
patient
experienc
wide
rang
possibl
advers
effect
advers
effect
includ
system
inflammatori
respons
syndrom
hypotens
elev
transaminas
level
transfusionassoci
acut
lung
injuri
interest
note
two
agent
felt
promis
begin
outbreak
ultim
found
offer
surviv
benefit
see
use
therapeut
vaccin
resourcelimit
environ
face
number
challeng
includ
suppli
distribut
uncertainti
administr
difficulti
agent
must
given
parenter
intraven
difficulti
util
oral
agent
patient
intract
nausea
emesi
imper
search
magic
bullet
detract
focu
suppli
aggress
support
care
patient
present
ebola
viru
infect
therapeut
current
consid
best
candid
efficaci
patient
infect
ebola
viru
fall
two
categori
boost
passiv
immun
pharmaceut
antivir
recoveri
ebola
viru
diseas
associ
product
antibodi
viru
therefor
hypothes
boost
passiv
immun
host
produc
antibodi
may
benefit
prior
outbreak
patient
ebola
viru
infect
given
whole
blood
outbreak
survivor
seven
patient
surviv
mortal
rate
compar
mortal
rate
patient
receiv
transfus
howev
due
small
number
confound
factor
surviv
differ
felt
definit
evid
efficaci
studi
convalescnet
serum
non
human
primat
inconclus
administr
convalesc
whole
blood
transfus
rhesu
macaqu
found
protect
infect
rhesu
macaqu
receiv
multipl
administr
purifi
polyclon
speciesmatch
igg
vaccin
anim
appear
protect
addit
use
convalesc
antibodi
pool
antibodi
produc
vitro
studi
zmapp
combin
chimer
humanmurin
monoclon
antibodi
produc
tobacco
plant
nicotiana
benthamiana
recent
develop
non
human
primat
trial
zmapp
protect
ebola
viru
infect
even
administ
day
anim
infect
anecdot
evid
support
efficaci
prepar
patient
surviv
current
outbreak
random
control
studi
complet
date
definit
answer
role
passiv
immun
treat
patient
ebola
viru
diseas
await
robust
trial
human
pharmaceut
antivir
direct
ebola
viru
fallen
two
categori
smallmolecul
inhibitor
viru
entri
endosom
escap
compound
block
viral
replic
first
categori
product
call
small
interf
ribonucl
acid
silenc
rna
replic
enzymat
cleavag
mrna
target
l
polymeras
viral
protein
guinea
pig
non
human
primat
challeng
studi
agent
found
offer
protect
unfortun
one
random
control
trial
human
perform
current
outbreak
agent
found
offer
surviv
advantag
human
trial
halt
favipiravir
broad
spectrum
antivir
inhibit
rnadepend
rna
polymeras
also
show
promis
initi
anim
studi
found
offer
surviv
advantag
random
trial
involv
human
howev
post
hoc
analysi
suggest
favipiravir
might
benefit
patient
present
earli
diseas
lower
viral
load
agent
shown
promis
vitro
anim
studi
includ
agent
evalu
random
human
trial
efficaci
human
yet
determin
high
mortal
rate
associ
ebola
viru
infect
ad
urgenc
search
effect
vaccin
practic
difficulti
perform
control
clinic
trial
ebola
vaccin
ebola
outbreak
tend
unpredict
sporad
ethic
concern
use
placebo
control
face
exposur
highli
lethal
diseas
fda
promulg
anim
rule
altern
pathway
licens
product
highli
lethal
pathogen
ebola
anim
rule
condit
anim
efficaci
data
glp
immun
correl
establish
protect
anim
human
safeti
immunogen
data
gcp
induct
immun
correl
human
anticip
effect
vaccin
need
elicit
humor
cell
mediat
immun
ebola
viru
vaccin
preexposur
identifi
exposur
viru
postexposur
identifi
exposur
viru
use
slightli
differ
requir
vaccin
preexposur
use
would
optim
induc
protect
one
vaccin
protect
multipl
strain
ebola
viru
minim
advers
effect
vaccin
postexposur
use
produc
rapid
induct
immun
vaccin
abil
toler
suboptim
storag
condit
import
given
suppli
chain
issu
part
world
ebola
viru
endem
attenu
inactiv
vaccin
shown
protect
nonhuman
primat
studi
safeti
concern
due
risk
incomplet
inactiv
genet
subunit
vaccin
result
incomplet
protect
lead
candid
vaccin
present
time
vectorbas
live
recombin
vesicular
stomat
viru
vsv
vaccin
replicationincompet
adenovir
vector
vaccin
vaccin
promot
immun
ebola
viru
glycoprotein
ebola
viru
glycoprotein
respons
attach
fusion
viral
host
membran
produc
inhibit
host
immun
respons
non
human
primat
model
antiglycoprotein
antibodi
level
allow
anim
surviv
subsequ
lethal
challeng
ebola
viru
vsv
vaccin
encod
ebola
glycoprotein
instead
vsv
glycoprotein
immun
produc
vaccin
primarili
humor
non
human
primat
one
dose
vaccin
induc
immun
protect
month
vaccin
viru
capabl
replic
major
volunt
exhibit
advers
event
report
system
symptom
includ
fever
chill
myalgia
headach
pre
exposur
studi
vaccin
limit
one
post
exposur
studi
individu
guinea
contact
patient
laboratori
confirm
evd
vaccin
either
immedi
day
follow
exposur
immedi
vaccin
group
case
ebola
viru
diseas
symptom
onset
least
day
random
wherea
delay
vaccin
group
case
ebola
viru
diseas
seven
cluster
show
vaccin
efficaci
adenoviru
vaccin
encod
ebola
glycoprotein
two
ebola
strain
zair
sudan
unlik
vsv
vaccin
promot
cellular
well
humor
immun
preexist
immun
adenoviru
common
immun
vsv
altern
immun
strategi
multipl
dose
must
util
human
volunt
minor
advers
reaction
seen
fever
transient
leukopenia
human
trial
endem
area
plan
prior
west
africa
evd
outbreak
rel
limit
data
medic
literatur
help
guid
infect
control
practic
care
patient
evd
unit
state
literatur
avail
base
experi
care
patient
evd
central
africaa
set
markedli
differ
modern
hospit
unit
state
decemb
patient
evd
treat
unit
state
ten
patient
treat
special
biocontain
patient
care
unit
emori
univers
hospit
univers
nebraska
medic
center
nation
institut
health
clinic
center
eleventh
care
isol
unit
develop
bellevu
hospit
center
set
key
lesson
learn
guid
infect
control
polici
procedur
safe
care
patient
evd
seriou
communic
diseas
although
biocontain
patient
care
unit
requir
treat
patient
evd
specif
featur
design
facil
make
ideal
environ
effect
treat
patient
seriou
communic
diseas
minim
risk
transmiss
healthcar
worker
patient
public
biocontain
patient
care
unit
includ
seriou
communic
diseas
unit
scdu
emori
univers
hospit
see
figur
individu
patient
care
room
design
deliv
level
care
equival
standard
icu
allow
healthcar
worker
provid
aggress
support
care
patient
may
critic
ill
maintain
staff
safeti
scdu
includ
dedic
space
staff
chang
area
store
person
protect
equip
ppe
patient
care
room
construct
seamless
surfac
wall
floor
facilit
effect
surfac
disinfect
maintain
safeti
hospit
patient
healthcar
worker
scdu
locat
secur
area
emori
univers
hospit
separ
patient
care
area
entranc
exit
scdu
continu
monitor
limit
healthcar
worker
individu
author
unit
scdu
also
design
safe
care
patient
diseas
unlik
ebola
spread
airborn
rout
specif
air
patient
room
net
neg
pressur
rel
surround
area
air
patient
room
laminar
air
flow
across
patient
bed
air
patient
room
undergo
higheffici
particul
air
filtrat
exhaust
outsid
outsid
exhaust
geograph
separ
hospit
air
intak
locat
high
enough
allow
dilut
disburs
independ
specif
design
featur
treatment
facil
west
african
evd
outbreak
clearli
demonstr
establish
train
compet
interdisciplinari
team
provid
emphas
cultur
safeti
critic
effect
care
patient
evd
staff
scdu
core
team
nurs
physician
healthcar
worker
expertis
infecti
diseas
critic
care
express
interest
care
patient
seriou
communic
diseas
identifi
order
part
team
provid
requir
demonstr
commit
practic
promot
cultur
safeti
cultur
safeti
team
member
commit
strictli
adher
safe
effect
practic
outlin
standard
oper
protocol
empow
ask
question
voic
concern
aris
team
member
also
requir
meet
follow
criteria
particip
regularli
schedul
drill
exercis
demonstr
compet
infect
control
practic
specif
emphasi
protocol
don
dof
ppe
specimen
handl
wast
manag
provid
unabl
demonstr
compet
permit
provid
direct
patient
care
patient
evd
drill
train
session
compet
verif
perform
everi
month
select
appropri
ppe
clinic
care
team
critic
step
maintain
staff
safeti
care
patient
evd
specif
type
ppe
use
healthcar
worker
care
patient
evd
includ
coveral
surgic
gown
head
cover
leav
skin
expos
apron
shoe
cover
ad
high
risk
exposur
infecti
bodi
fluid
least
two
set
glove
worn
includ
outer
glove
extend
cuff
although
ebola
viru
transmit
air
wear
power
air
purifi
respir
respir
togeth
faceshield
protect
face
mucu
membran
exposur
infecti
fluid
provid
addit
protect
aerosolgener
procedur
perform
regardless
specif
type
ppe
select
imper
ppe
provid
adequ
protect
remain
comfort
healthcar
worker
especi
import
direct
care
provid
receiv
adequ
train
demonstr
compet
don
dof
ppe
inappropri
don
dof
ppe
identifi
possibl
risk
factor
evd
acquisit
among
healthcar
worker
therefor
imper
healthcar
worker
don
dof
ppe
alway
monitor
partner
ensur
strict
adher
proper
procedur
addit
core
group
nurs
physician
provid
direct
care
patient
evd
laboratori
technologist
critic
member
interdisciplinari
team
need
maintain
strict
adher
infect
control
practic
patient
evd
high
viral
load
reach
level
viral
particlesml
bodi
fluid
ebola
viru
highli
infecti
infecti
dose
estim
low
ml
blood
result
critic
hospit
care
patient
evd
develop
detail
standard
oper
protocol
maintain
safeti
laboratori
specimen
collect
transport
process
guidelin
center
diseas
control
prevent
cdc
state
hospit
clinic
laboratori
safe
handl
specimen
patient
evd
risk
mitig
strategi
engin
control
administr
work
control
use
appropri
ppe
implement
american
societi
microbiolog
howev
issu
guidelin
suggest
specimen
patient
evd
limit
pointofcar
poc
test
equip
perform
either
patient
room
biolog
safeti
cabinet
isol
area
scdu
emori
univers
hospit
establish
selfcontain
poc
laboratori
process
specimen
within
laminar
flow
biosafeti
contain
hood
laboratori
technologist
involv
transport
process
specimen
contain
ebola
viru
receiv
ppe
train
demonstr
compet
don
dof
hospit
prepar
care
patient
evd
also
requir
multidisciplinari
team
develop
standard
protocol
manag
regul
medic
wast
team
includ
environment
servic
infect
prevent
control
biosafeti
offic
hospit
administr
public
health
offici
other
expertis
hazard
wast
remov
wast
patient
evd
dispos
complianc
local
state
feder
regul
evd
patient
care
wast
defin
regul
unit
state
depart
transport
categori
infecti
substanc
therefor
solid
medic
wast
gener
scdu
care
patient
evd
steril
autoclav
allow
wast
transport
dispos
safe
regular
medic
wast
unit
access
autoclav
contractor
transport
dispos
categori
wast
special
procedur
place
packag
wast
although
cdc
guidelin
state
liquid
wast
may
dispos
without
treatment
sanitari
sewer
local
wast
treatment
author
may
differ
requir
scdu
disinfect
ad
liquid
wast
accord
manufactur
direct
prior
dispos
sanitari
sewer
low
infecti
dose
ebola
viru
health
care
worker
care
patient
evd
must
develop
standard
protocol
ensur
environment
surfac
direct
patient
care
area
laboratori
wast
stream
receiv
regular
clean
appropri
effect
disinfect
unit
state
environment
protect
agenc
epa
identifi
eparegist
disinfect
label
claim
potenc
least
equival
nonenvelop
viru
meet
cdc
criteria
use
ebola
viru
disinfect
use
train
health
care
worker
accord
manufactur
instruct
strict
adher
regular
clean
significantli
reduc
risk
ebola
viru
transmiss
bodili
fluid
fomit
environ
termin
clean
environ
discharg
patient
ebola
viru
diseas
essenti
meticul
attent
paid
disinfect
surfac
unit
follow
supplement
disinfect
modal
vapor
hydrogen
peroxid
uv
gener
one
key
lesson
ebola
outbreak
taught
us
unit
state
world
ill
prepar
address
outbreak
emerg
infecti
diseas
lesson
particularli
jar
given
outbreak
sar
sever
acut
respiratori
syndrom
influenza
mer
middl
east
respiratori
syndrom
mark
last
decad
partial
due
lack
prepar
ebola
outbreak
dwarf
outbreak
ebola
viru
diseas
term
number
infect
mortal
intern
front
factor
identifi
contribut
unpreced
extent
outbreak
identifi
tabl
addit
lack
prepared
isol
manag
infect
patient
delay
implement
research
protocol
evalu
treatment
algorithm
therapeut
agent
vaccin
mean
mani
question
regard
intervent
resolv
prior
next
outbreak
respons
outbreak
mani
initi
global
unit
state
begun
intern
arena
independ
multin
commiss
global
health
risk
framework
futur
establish
recommend
effect
global
architectur
mitig
threat
epidem
infecti
diseas
us
nation
academi
medicin
secretariat
commiss
addit
independ
panel
conven
world
health
organ
propos
agenda
chang
tabl
larg
accept
administr
unit
state
also
wit
mark
increas
activ
focus
emerg
prepared
emerg
infecti
diseas
congress
appropri
billion
effort
control
ebola
viru
infect
fund
util
address
number
area
requir
strengthen
order
improv
us
respons
emerg
infecti
diseas
hospit
prepared
program
assist
secretari
prepared
respons
aspr
fund
distribut
state
grante
enhanc
state
local
healthcar
system
prepared
fund
also
design
creat
one
region
ebola
special
pathogen
treatment
center
ten
health
human
servic
region
addit
center
diseas
control
prevent
develop
tier
approach
manag
patient
possibl
confirm
ebola
viru
diseas
infect
caus
seriou
communic
pathogen
strategi
acut
healthcar
facil
serv
one
three
role
frontlin
healthcar
facil
ebola
assess
hospit
ebola
treatment
center
frontlin
healthcar
facil
coordin
local
state
health
author
abl
rapidli
identifi
triag
patient
suspect
infect
ebola
viru
ebola
assess
hospit
facil
prepar
receiv
isol
suspect
patient
care
patient
diagnosi
ebola
viru
diseas
confirm
rule
discharg
transfer
complet
ebola
treatment
center
facil
plan
care
manag
patient
confirm
ebola
viru
diseas
durat
patient
ill
ebola
viru
outbreak
west
africa
contain
focu
network
gradual
shift
seriou
communic
diseas
although
exactli
infecti
diseas
yet
resolv
aspr
also
fund
nation
ebola
train
educ
center
netec
develop
robust
educ
program
improv
infecti
diseas
emerg
prepared
unit
state
netec
use
multiprong
approach
includ
site
visit
region
ebola
treatment
unit
establish
web
base
learn
manag
system
develop
exercis
templat
entiti
test
state
prepared
research
agenda
answer
fundament
question
regard
treatment
patient
ebola
viru
diseas
seriou
communic
pathogen
goal
site
visit
exercis
demonstr
institutionwid
approach
essenti
come
manag
patient
seriou
communic
diseas
area
prepared
receiv
target
attent
list
tabl
one
challeng
area
mani
facil
develop
laboratori
safe
evalu
patient
seriou
communic
pathogen
time
manner
time
test
common
rapidli
fatal
diseas
malaria
typhoid
fever
evd
outbreak
began
guinea
decemb
largest
deadliest
evd
outbreak
human
histori
outbreak
cruelli
demonstr
signific
degre
develop
nation
like
west
africa
vulner
seriou
morbid
mortal
caus
rapid
spread
seriou
communic
diseas
like
evd
paradox
outbreak
also
result
largest
number
evd
survivor
histori
therefor
critic
unpreced
intern
respons
help
end
evd
outbreak
sustain
build
infrastructur
vulner
develop
nation
build
maintain
adequ
healthcar
infrastructur
critic
manag
preval
poorli
understood
complic
occur
evd
survivor
well
prevent
futur
outbreak
west
african
evd
outbreak
also
demonstr
emerg
infecti
diseas
border
imper
develop
nation
advanc
healthcar
system
like
unit
state
identifi
lesson
learn
west
african
evd
outbreak
specif
key
lesson
learn
domain
safe
effect
patient
care
role
experiment
therapeut
vaccin
infect
control
hospit
commun
prepared
hope
help
unit
state
intern
commun
effect
respond
futur
outbreak
evd
emerg
seriou
communic
diseas
futur
